Reckitt Benckiser Group (LON:RKT) Hits New 1-Year High – What’s Next?

Reckitt Benckiser Group plc (LON:RKT)’s stock price reached a new 52-week high on Thursday . The stock traded as high as GBX 5,386 ($69.43) and last traded at GBX 5,356 ($69.04), with a volume of 15833262 shares trading hands. The stock had previously closed at GBX 5,186 ($66.85).

Reckitt Benckiser Group Price Performance

The company has a current ratio of 0.69, a quick ratio of 0.46 and a debt-to-equity ratio of 110.26. The firm has a market cap of £36.36 billion, a P/E ratio of 24.39, a PEG ratio of 1.10 and a beta of 0.09. The company has a fifty day moving average price of GBX 5,106.99 and a two-hundred day moving average price of GBX 4,828.16.

Insider Activity

In related news, insider Shannon Eisenhardt sold 1,368 shares of Reckitt Benckiser Group stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of GBX 4,723 ($60.88), for a total value of £64,610.64 ($83,282.60). 0.05% of the stock is currently owned by company insiders.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.